IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a synthetic research peptide engineered to enhance stability, potency, and biological activity compared to native IGF-1. With a modified amino acid sequence that significantly reduces binding affinity to IGF-binding proteins (IGFBPs), IGF-1 LR3 allows researchers to study unrestricted IGF-1 pathway activity, making it a centerpiece in advanced cellular and metabolic research
As the fourth most common cancer in women in terms of new cases, EC incidences have been rapidly increasing over the last 10 years as a consequence of a higher overall prevalence of obesity and metabolic syndromes 4,5
The results were confirmed for the non-related enzyme PfGrx with its homologous residues Lys26 and Asp90
So, Id say its a real little helper, plus it gives great hydration
As with any injectable treatment, there is a risk of allergic reactions, including rare but serious events such as anaphylaxis